Association between diabetes and amyotrophic lateral sclerosis in Sweden
- PMID: 25600257
- PMCID: PMC4506907
- DOI: 10.1111/ene.12632
Association between diabetes and amyotrophic lateral sclerosis in Sweden
Abstract
Background and purpose: Energy metabolism is altered in patients with amyotrophic lateral sclerosis (ALS) but the role of diabetes is largely unknown.
Methods: A population-based case-control study was conducted of 5108 ALS cases and 25,540 individually matched population controls during 1991-2010. Information on ALS and pre-existing diabetes was retrieved from the Swedish Patient Register to explore the association of ALS with diabetes overall and with insulin-dependent or non-insulin-dependent diabetes specifically. Variation of the association by diabetes duration and age was also studied.
Results: In total, 224 ALS cases (4.39%) and 1437 controls (5.63%) had diabetes before the index date, leading to an overall inverse association between diabetes and ALS risk [odds ratio (OR) 0.79, 95% confidence interval (CI) 0.68-0.91]. The association was strong for non-insulin-dependent diabetes (OR 0.66, 95% CI 0.53-0.81) but not for insulin-dependent diabetes (OR 0.83, 95% CI 0.60-1.15) and varied as a function of diabetes duration, with the strongest association observed around 6 years after first ascertainment of diabetes. The association was age-specific; the inverse association was noted only amongst individuals aged 70 or older. In contrast, for younger individuals (<50 years), pre-existing insulin-dependent diabetes was associated with a higher ALS risk (OR 5.38, 95% CI 1.87-15.51).
Conclusions: Our study suggests that there is an association between diabetes and ALS, and highlights the importance of taking into account age, insulin dependence and diabetes duration. Future studies should explore whether the association is independent of body mass index.
Keywords: amyotrophic lateral sclerosis; diabetes; epidemiology; insulin dependence; metabolic and endocrine disorders; motor neuron disease; neurological disorders; neuromuscular diseases; research methods.
© 2015 EAN.
Conflict of interest statement
Figures
Comment in
-
Diabetes mellitus in amyotrophic lateral sclerosis: Dr. Jekyll or Mr. Hyde?Eur J Neurol. 2015 Nov;22(11):1419-20. doi: 10.1111/ene.12660. Epub 2015 Jan 18. Eur J Neurol. 2015. PMID: 25597340 No abstract available.
-
Type 2 diabetes and amyotrophic lateral sclerosis.Eur J Neurol. 2016 Feb;23(2):e9. doi: 10.1111/ene.12893. Eur J Neurol. 2016. PMID: 26806221 No abstract available.
-
Response to the letter 'Type 2 diabetes and amyotrophic lateral sclerosis'.Eur J Neurol. 2016 Apr;23(4):e26. doi: 10.1111/ene.12928. Eur J Neurol. 2016. PMID: 27000982 No abstract available.
Similar articles
-
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.JAMA Neurol. 2015 Aug;72(8):905-11. doi: 10.1001/jamaneurol.2015.0910. JAMA Neurol. 2015. PMID: 26030836 Free PMC article.
-
The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis.Eur J Neurol. 2018 Jan;25(1):164-170. doi: 10.1111/ene.13465. Epub 2017 Oct 21. Eur J Neurol. 2018. PMID: 28921834
-
Association of alcohol use disorders with amyotrophic lateral sclerosis: a Swedish national cohort study.Eur J Neurol. 2016 Feb;23(2):270-5. doi: 10.1111/ene.12667. Epub 2015 Jan 29. Eur J Neurol. 2016. PMID: 25641323
-
Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference.Neuroepidemiology. 2019;52(1-2):93-103. doi: 10.1159/000493386. Epub 2019 Jan 2. Neuroepidemiology. 2019. PMID: 30602169 Review.
-
The links between diabetes mellitus and amyotrophic lateral sclerosis.Neurol Sci. 2021 Apr;42(4):1377-1387. doi: 10.1007/s10072-021-05099-0. Epub 2021 Feb 5. Neurol Sci. 2021. PMID: 33544228 Free PMC article. Review.
Cited by
-
Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis.Neurol Sci. 2022 Sep;43(9):5189-5199. doi: 10.1007/s10072-022-06131-7. Epub 2022 May 26. Neurol Sci. 2022. PMID: 35616813 Review.
-
Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review.Biomolecules. 2021 Jun 10;11(6):867. doi: 10.3390/biom11060867. Biomolecules. 2021. PMID: 34200812 Free PMC article.
-
Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases.Biomed Res Int. 2017;2017:7973165. doi: 10.1155/2017/7973165. Epub 2017 Feb 23. Biomed Res Int. 2017. PMID: 28326328 Free PMC article. Review.
-
Impact of diabetes mellitus on the respiratory function of amyotrophic lateral sclerosis patients.Eur J Neurol. 2024 Feb;31(2):e16129. doi: 10.1111/ene.16129. Epub 2023 Nov 13. Eur J Neurol. 2024. PMID: 37955564 Free PMC article.
-
Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration.Commun Biol. 2022 Dec 7;5(1):1340. doi: 10.1038/s42003-022-04295-8. Commun Biol. 2022. PMID: 36477191 Free PMC article.
References
-
- Fang F, Valdimarsdottir U, Bellocco R, et al. Amyotrophic lateral sclerosis in Sweden, 1991–2005. Archives of neurology. 2009;66(4):515–9. - PubMed
-
- Korner S, Kollewe K, Ilsemann J, et al. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2013;20(4):647–54. - PubMed
-
- Kalkonde YV, Jawaid A, Qureshi SU, et al. Medical and environmental risk factors associated with frontotemporal dementia: a case-control study in a veteran population. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2012;8(3):204–10. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
